Nikhil Lalwani - 11 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
11 Feb 2026
Net transactions value
-$2,337,749
Form type
4
Filing time
13 Feb 2026, 16:09:48 UTC
Previous filing
14 Aug 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lalwani Nikhil PRESIDENT & CEO, Director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook 13 Feb 2026 0001822629

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $2,337,749 -30,659 -7.5% $76.25 380,560 11 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 63,686 performance stock units, the grant of which was previously reported on April 6, 2023.